In the present study, we found that the SOD, GPX, and CAT activity levels were upregulated after 10 weeks of CS administration, indicating that CS could inhibit oxidative stress in type 1 diabetic rats; this may be one of important reasons why CS could prevent bone loss in type 1 diabetic rats. The gene discussed is CAT; the disease is type 1 diabetes mellitus.